BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4388802)

  • 1. [Clinical analysis using a new antihistaminics (HS-592)].
    Lahoz F; Marín F; Sastre A; Pérez Guerrero J
    Rev Clin Esp; 1969 Jan; 112(2):175-82. PubMed ID: 4388802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case reports in clinical treatment with a synthetic antihistaminic: HS 592].
    Giamperi M
    Folia Allergol (Roma); 1971; 18(1):69-82. PubMed ID: 4397373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology].
    Laverone F
    Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1217-24. PubMed ID: 4389858
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of various new antihistaminics].
    van der Bijl WJ
    Ned Tijdschr Geneeskd; 1970 Feb; 114(8):358-60. PubMed ID: 4391853
    [No Abstract]   [Full Text] [Related]  

  • 5. A new antihistaminic drug (Tavegyl) in allergic diseases.
    Hajós M
    Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of therapeutic effect of antihistaminics---clinical effect of HS 592].
    Okuda M; Sekine K
    Jibiinkoka; 1970 Jul; 42(7):555-7. PubMed ID: 4394032
    [No Abstract]   [Full Text] [Related]  

  • 7. [The place of antihistaminics in the modern therapy of allergy].
    Wodniansky P
    Wien Klin Wochenschr; 1970 Mar; 82(10):178-80. PubMed ID: 4399721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of a new antihistaminic: HS-592].
    von Bernath Z
    Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antihistaminic in the treatment of allergic diseases].
    Basomba A; Oehling A
    Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new sweating and anti-pruriginosis drug in the management of skin allergies].
    Foigel S
    Hospital (Rio J); 1969 Jan; 75(1):317-21. PubMed ID: 4387991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
    De Caro L; Rizzo SC
    Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies on the new antihistaminic Tavegil].
    Römer D; Weidmann H
    Med Welt; 1966 Dec; 51():2791-4. PubMed ID: 4382572
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic observations with Tavegyl.
    Pólay A
    Ther Hung; 1980; 28(2):82-6. PubMed ID: 6110250
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tavegyl in treatment of allergic skin diseases].
    Kibler-Nockowska M
    Wiad Lek; 1974 Apr; 27(7):645-8. PubMed ID: 4151284
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the clinical study of HS-592 in allergic manifestations].
    da Rocha JM
    Hospital (Rio J); 1969 Jan; 75(1):313-5. PubMed ID: 4387990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihistaminic-corticoid combinations in allergy].
    Basomba Riba A; García Villalmanzo I; Baguena Candela J
    Rev Clin Esp; 1973 Dec; 131(6):491-500. PubMed ID: 4149906
    [No Abstract]   [Full Text] [Related]  

  • 17. A new antihistamine in the treatment of allercig disease.
    Basomba A; Oehling A
    Allerg Asthma (Leipz); 1969; 15(1):54-60. PubMed ID: 4391901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Utilization of new antihistaminic medication in the infant and child: HS 592].
    Carron R; Michel M
    Lyon Med; 1967 Sep; 218(36):361-4. PubMed ID: 4390427
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihistamic Tavegil in allergies of upper respiratory tract and itching dermatoses].
    Maiss HJ
    Ther Ggw; 1969 Oct; 108(10):1469 passim. PubMed ID: 4392349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with the HS-592 in the dysreactive, allergy and exudative processes in E.N.T].
    Sánchez García J
    Acta Otorinolaryngol Iber Am; 1969; 20(6):645-57. PubMed ID: 4393808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.